Can darolutamide plus ADT delay pain progression in metastatic hormone-sensitive prostate cancer?
For men with metastatic hormone-sensitive prostate cancer (mHSPC), controlling pain is a key treatment goal alongside slowing cancer growth. The phase 3 ARANOTE trial specifically examined whether adding darolutamide to standard androgen-deprivation therapy (ADT) could delay pain worsening. The answer is yes: darolutamide plus ADT significantly delayed pain progression compared to ADT alone, while also improving other outcomes like delaying the time to castration-resistant disease.
What the research says
The ARANOTE trial, a large international phase 3 study, randomly assigned 669 men with mHSPC to receive either darolutamide (600 mg twice daily) plus ADT or placebo plus ADT 68. The primary result showed that darolutamide reduced the risk of radiological progression or death by 46% (hazard ratio 0.54) 68. Importantly, secondary analyses focused on pain and quality of life. Darolutamide plus ADT significantly delayed time to pain progression compared to placebo plus ADT 38. This means patients on darolutamide experienced worsening of pain later than those on ADT alone. The study also found that darolutamide delayed time to metastatic castration-resistant prostate cancer (mCRPC) by 60% (hazard ratio 0.40) 6. A real-world study comparing darolutamide to abiraterone acetate plus prednisone (both with ADT) also reported that darolutamide delayed time to pain progression, though the follow-up was shorter (median 12 months) 7. Overall, the evidence from the ARANOTE trial provides strong support that darolutamide plus ADT helps maintain pain control longer than ADT alone in mHSPC.
What to ask your doctor
- Based on my disease characteristics (high-volume vs low-volume), how much might darolutamide plus ADT delay pain progression for me?
- What are the common side effects of darolutamide, and how do they compare to other hormone therapy options?
- How does the ARANOTE trial's pain progression data apply to my treatment plan?
- Should I consider darolutamide plus ADT even if I don't have pain now, to prevent future pain?
- What other quality-of-life benefits might I expect from adding darolutamide to ADT?
This question is drawn from common patient questions about Urology and answered using cited medical research. We do not provide individualized advice.